121 related articles for article (PubMed ID: 7999597)
41. Dermal collagen production following irradiation by dye laser and broadband light source.
Bjerring P; Clement M; Heickendorff L; Lybecker H; Kiernan M
J Cosmet Laser Ther; 2002 Jun; 4(2):39-43. PubMed ID: 12470517
[TBL] [Abstract][Full Text] [Related]
42. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy.
Kjeldsen J; Schaffalitzky de Muckadell OB; Junker P
Gut; 1995 Dec; 37(6):805-10. PubMed ID: 8537052
[TBL] [Abstract][Full Text] [Related]
43. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
[TBL] [Abstract][Full Text] [Related]
44. A chemically modified tetracycline inhibits streptozotocin-induced diabetic depression of skin collagen synthesis and steady-state type I procollagen mRNA.
Craig RG; Yu Z; Xu L; Barr R; Ramamurthy N; Boland J; Schneir M; Golub LM
Biochim Biophys Acta; 1998 Apr; 1402(3):250-60. PubMed ID: 9606983
[TBL] [Abstract][Full Text] [Related]
45. Detection of meningeal fibrosis after subarachnoid haemorrhage by assaying procollagen propeptides in cerebrospinal fluid.
Sajanti J; Majamaa K
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):185-8. PubMed ID: 10406986
[TBL] [Abstract][Full Text] [Related]
46. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
Ruf G; Mappes HJ; Koch H; Baumgartner U; Hagmann W; Farthmann EH
Hepatogastroenterology; 1996; 43(7):121-6. PubMed ID: 8682446
[TBL] [Abstract][Full Text] [Related]
47. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator.
Peuhkurinen K; Risteli L; Jounela A; Risteli J
Am Heart J; 1996 Jan; 131(1):7-13. PubMed ID: 8554022
[TBL] [Abstract][Full Text] [Related]
48. A thyroid hormone analogue, triiodothyroacetic acid, corrects corticosteroid-downregulated collagen synthesis.
Yazdanparast P; Carlsson B; Oikarinen A; Risteli J; Faergemann J
Thyroid; 2004 May; 14(5):345-53. PubMed ID: 15186610
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes.
Meisler N; Shull S; Xie R; Long GL; Absher M; Connolly JP; Cutroneo KR
J Cell Biochem; 1995 Nov; 59(3):376-88. PubMed ID: 8567755
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of type I collagen in healing wounds in humans.
Haukipuro K; Melkko J; Risteli L; Kairaluoma M; Risteli J
Ann Surg; 1991 Jan; 213(1):75-80. PubMed ID: 1985542
[TBL] [Abstract][Full Text] [Related]
51. Assays of type I procollagen domains and collagen fragments: problems to be solved and future trends.
Risteli J; Risteli L
Scand J Clin Lab Invest Suppl; 1997; 227():105-13. PubMed ID: 9127476
[TBL] [Abstract][Full Text] [Related]
52. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
[TBL] [Abstract][Full Text] [Related]
53. Skin scoring in systemic sclerosis: a modification--relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP).
Zachariae H; Bjerring P; Halkier-Sørensen L; Heickendorff L; Søndergaard K
Acta Derm Venereol; 1994 Nov; 74(6):444-6. PubMed ID: 7701875
[TBL] [Abstract][Full Text] [Related]
54. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial.
Reitamo S; Rissanen J; Remitz A; Granlund H; Erkko P; Elg P; Autio P; Lauerma AI
J Invest Dermatol; 1998 Sep; 111(3):396-8. PubMed ID: 9740230
[TBL] [Abstract][Full Text] [Related]
55. Aminoterminal propeptide of type III procollagen in healing wound in humans.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Ann Surg; 1987 Dec; 206(6):752-6. PubMed ID: 3689011
[TBL] [Abstract][Full Text] [Related]
56. Collagen biosynthesis by human skin fibroblasts. II. Isolation and further characterization of type I and type III procollagens synthesized in culture.
Uitto J; Booth BA; Polak KL
Biochim Biophys Acta; 1980 Aug; 624(2):545-61. PubMed ID: 7417491
[TBL] [Abstract][Full Text] [Related]
57. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
Cantin AM; Boileau R; Bégin R
Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
[TBL] [Abstract][Full Text] [Related]
58. Collagen biosynthesis by human skin fibroblasts. I. Optimization of the culture conditions for synthesis of type I and type III procollagens.
Booth BA; Polak KL; Uitto J
Biochim Biophys Acta; 1980 Mar; 607(1):145-60. PubMed ID: 7370260
[TBL] [Abstract][Full Text] [Related]
59. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
60. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
